# POL_Mut

There is the analysis R code for this paper. Analysis Data is not provided.
>"A phase II clinical trial of toripalimab in advanced solidtumors with polymerase epsilon/polymerase delta (POLE/POLD1) mutation" 
>Ying Jin, Run-Jie Huang, Wen-Long Guan, Zhi-Qiang Wang, Zong-Jiong Mai, Yu-Hong Li, Jian Xiao, Xing Zhang,Qi Zhao, Shi-Fu Chen, Ming Liu, Yan-Xia Shi, Feng Wang and Rui-Hua Xu

* MutationSignature.R for Supplement Figure 1
* DynamicsctDNAChangeAnalysis.R for Supplement Figure 5
